articleThe Journal of Experimental MedicineFeb 11, 2008BRONZE OA

IL-33 reduces the development of atherosclerosis

British Heart Foundation · University of Glasgow

PubMed
Indexed incrossrefpubmed

Abstract

Atherosclerosis is a chronic inflammatory disease of the vasculature commonly leading to myocardial infarction and stroke. We show that IL-33, which is a novel IL-1-like cytokine that signals via ST2, can reduce atherosclerosis development in ApoE(-/-) mice on a high-fat diet. IL-33 and ST2 are present in the normal and atherosclerotic vasculature of mice and humans. Although control PBS-treated mice developed severe and inflamed atherosclerotic plaques in the aortic sinus, lesion development was profoundly reduced in IL-33-treated animals. IL-33 also markedly increased levels of IL-4, -5, and -13, but decreased levels of IFNgamma in serum and lymph node cells. IL-33 treatment also elevated levels of total…

Citation impact

635
total citations
FWCI
13.42
Percentile
100%
References
31
Citations per year

Authors

9

Topics & keywords

Keywords
  • Medicine
  • Antibody
  • Aortic sinus
  • Lesion
  • Receptor
  • Cytokine
  • Apolipoprotein E
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.